Skip to main content
Latest News
June 8, 2026
Mariska Hargitay Partners with Bristol Myers Squibb for “Investigating Myeloma” Awareness Campaign to Honor Her Father 20 Years After Losing Him to the Disease
June 2, 2026
Izalontamab Brengitecan (Iza-Bren) Demonstrates Statistically Significant and Clinically Meaningful Improvements in Overall Survival and Progression-Free Survival in Patients with Triple-Negative Breast Cancer and Esophageal Squamous Cell Carcinoma
June 1, 2026
U.S. Food and Drug Administration Accepts for Priority Review Bristol Myers Squibb’s Supplemental New Drug Application for Camzyos (mavacamten) to Treat Adolescents with Symptomatic Obstructive Hypertrophic Cardiomyopathy (oHCM)
Latest Events
Event year list
2026
2025
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
October 29, 2026
08:00 AM ET
Bristol Myers Squibb Q3 2026 Results Conference Call
July 30, 2026
08:15 AM ET
Bristol Myers Squibb Q2 2026 Results Conference Call
June 9, 2026
02:00 PM EST
Goldman Sachs 47th Annual Global Healthcare Conference
Webcast
(opens in new window)